Brk inhibitory compound
AssigneeOno Pharmaceutical Co., Ltd.
InventorsShingo Yamamoto, Hiroshi Tokura, Masakuni Kurono, Yoshinori Nomura, Shingo Hotta
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound represented by general formula (I) (wherein, all symbols represent the same meanings as the symbols set forth in the specification), a salt thereof, a solvate thereof, an N-oxide thereof, or a prodrug of any of these. Since the compound has a Brk inhibitory activity, the compound is useful as a drug ingredient for the prevention and/or treatment of Brk-related diseases such as cancer, for example.
Claims3
N6-(1,3-dimethyl-1H-pyrazol-4-yl)-3-(1H-indol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;
- a salt thereof, a solvate thereof, or an N-oxide thereof.
A compound represented by structural formula as below,
A salt of a compound represented by structural formula as below,
Dependencies are inferred from the claim text.